Vaccine shows therapeutic promise against advanced melanoma
Monday, June 1, 2009 - 08:42
in Health & Medicine
ORLANDO - A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.
Read the whole article on Science Blog
More from Science Blog
Related
- Vaccine shows therapeutic promise against advanced melanomaMon, 1 Jun 2009, 9:44:24 EDT
- Vandetanib shows clinical benefit when combined with docetaxel for lung cancerMon, 1 Jun 2009, 9:44:28 EDT
- Study shows cancer vaccines led to long-term survival for patients with metastatic melanomaTue, 28 Jul 2009, 13:55:44 EDT
- Novel 4-drug combination proves safe for lung cancer treatmentThu, 13 Nov 2008, 10:30:54 EST
- New therapeutic treatment approach improves survival in esophageal cancer patientsMon, 6 Oct 2008, 11:29:14 EDT